Official Journal December 1997
Article | Page(s) | View |
|---|---|---|
BOARDS OF APPEAL | ||
Information from the Enlarged Board of Appeal | ||
| Referrals by boards of appeal | 551 | |
Decisions of the Technical Boards of Appeal | ||
| Decision of Technical Board of Appeal 3.3.2 dated 20 December 1996 – W 4/96 | 552-560 | |
Decisions of the Disciplinary Board of Appeal | ||
| Decision of the Disciplinary Board of Appeal dated 5 June 1996 – D 14/93 | 561-571 | |
INFORMATION FROM THE EPO | ||
Information from the EPO | ||
| Information concerning interviews and oral proceedings to be held as a video conference | 572-574 | |
| Corrigendum: Composition of the Disciplinary Board of Appeal (OJ EPO 1997, 471) | 574 | |
| Information about the European Patent Office Web site on the Internet | 575 | |
| Register of European Patents on-line: further user possibilities | 576 | |
* * * | ||
| Official Journal Index, Year 20/1997 | Insert | |
REPRESENTATION | ||
European qualifying examination | ||
| European qualifying examination | 577 | |
List of professional representatives before the EPO | ||
| List of professional representatives before the EPO | 578-587 | |
INFORMATION FROM THE CONTRACTING / EXTENSION STATES | ||
DE Germany | ||
| Judgment of the Bundesgerichtshof (Federal Court of Justice), 10th Civil Senate, dated 11 July 1995 – Klinische Versuche (clinical tests) 'Right to conduct tests – use of patented subject-matter to gain information about possible further uses – right to test not limited by further-reaching objectives, eg approval under pharmaceuticals legislation' | 588 | |
| Judgment of the Bundesgerichtshof (Federal Court of Justice), 10th Civil Senate, dated 17 April 1997 – Klinische Versuche II (clinical tests II) 'Right to conduct tests – a commercial objective in tests for the purposes of technical development does not constitute patent infringement – limits of right to test' | 589 | |
INTERNATIONAL TREATIES | ||
EC Treaty | ||
| Judgment of the Court of Justice of the European Communities dated 9 July 1997 – Generics BV/Smith Kline 'Patent protection for direct product of a process – submission of medicinal product for marketing authorisation as infringement' – 'Infringer prohibited from marketing product for a period after expiry of patent' | 590-591 | |
PCT | ||
| Amendment of PCT Regulations | 592 | |
| Information for PCT applicants concerning the procedure before the EPO as an International Preliminary Examining Authority under Chapter II PCT | 593-600 | |
| Accession by Guinea-Bissau (GW) | 600 | |
FEES | ||
| Guidance for the payment of fees, costs and prices | 601 | |
| Important notice | 601 |